Easee Holding B.V. (Easee) was founded in 2016 with the ambition to push the industry of eye care forward and making the appropriate eye care for everyone accessible at any time, everywhere.
Myopia (nearsightedness) is a growing problem due to an aging population and increasing screen use among children. Severe myopia is an irreversible disease, which for 1 in 3 people can lead to even worse visual impairments such as blindness. With early diagnosis, however, myopia is easily treatable. But care capacity falls short in this regard. In the Netherlands, the average waiting time for a visit to an ophthalmologist is 91 days.
Easee offers a scalable solution to this growing problem: online eye testing. Easee is the world's first online eye testing platform to receive medical certification and has built a loyal user base since its launch in 2020. The unique and innovative platform enables eye clinics to serve 3 to 4 times as many people and significantly reduce wait times.
After seven years of product development, successful medical studies and an intensive certification process, Easee has established a solid foundation. Besides existing partners such as the leading university centers Oogziekenhuis Rotterdam, UMC Utrecht, and UMC Maastricht, and commercial partners such as Synsam, Zilveren Kruis and Hans Anders, Easee has recently concluded many new interesting collaborations, such as Harvard Medical School and Xpert Clinics. The promising software, impact and commercial possibilities of Easee do not go unnoticed. After winning the Rabobank Sustainable Innovation Award earlier this year and the recent announcement of the shortlist listing for an EIC-grant, Easee may now also share that they have been nominated again for the prestigious WSA Global Award 2024 in the category Health & Well Being.